425: Kimberly-Clark Posts Strong Q4 2025, Advances Kenvue Merger

Kimberly-Clark reported strong fourth-quarter and full-year 2025 results, driven by its Powering Care strategy, and is on track to complete its transformative Kenvue acquisition and International Family Care & Professional joint venture.

Summary

• Kimberly-Clark delivered strong Q4 and full-year 2025 results, reflecting enhanced business strength and resilience, driven by its 'Powering Care' strategy.
• The company is strategically pivoting its portfolio towards higher-growth, higher-margin personal care categories, including the sale of Brazilian Tissue Operations, PPE business, and exiting approximately $650 million of private label business.
• The pending acquisition of Kenvue is a powerful next step, aiming to create a $32 billion pure-play, global health & wellness leader with 10 iconic billion-dollar brands.
• The Kenvue transaction is expected to generate $2.1 billion in annual synergies (net of reinvestment), including $1.9 billion in cost synergies within the first three years, and solid EPS accretion by year two post-close.
• A joint venture with Suzano for International Family Care & Professional business, with Kimberly-Clark owning a 49% stake, is expected to complete by mid-2026.
• For 2026, the company targets organic growth in line with or ahead of category growth, mid-to-high single-digit constant-currency Adjusted Operating Profit growth, and double-digit constant-currency Adjusted EPS growth from Continuing Operations.
• Adjusted Free Cash Flow is projected at approximately $2 billion for 2025 and 2026, with capital investments accelerating to $1.3 billion in 2026.

Sentiment

Score: 9

Explanation: The filing conveys a highly positive sentiment, emphasizing strong performance in 2025, exceeding productivity targets, and successful strategic transformation. The Kenvue acquisition is presented as a "powerful next step" with significant synergy potential and long-term value creation, despite some near-term dilution. The 2026 outlook is described as "robust, achievable," with targets for continued growth and margin expansion.

Positives

• Delivered strong Q4 and full-year 2025 performance, demonstrating enhanced business strength and resilience.
• Achieved volume-plus-mix led organic growth of approximately 2% for the full year 2025, with Q4 volume-plus-mix growth of 3%.
• Delivered industry-leading gross productivity of 6.2% of adjusted COGS for FY25, peaking at 7.2% in Q4, exceeding the expected range of 5-6%.
• Expanded Adjusted Operating Profit margins by 180 basis points in the past two years, on pace to reach 18-20% before the end of the decade.
• Gained approximately 10 basis points in enterprise weighted share in 2025, with broad-based share gains in International Personal Care focus markets.
• The Kenvue acquisition is expected to generate $2.1 billion in annual synergies (net of reinvestment), with $1.9 billion in cost synergies targeted within the first three years.
• Anticipates solid EPS accretion from the Kenvue acquisition in year two following close.
• Improved cash conversion cycle from 6 days in 2021 to approximately -10 days at the close of 2025.
• Maintained a robust balance sheet with leverage below the 2.0x Net Debt-to-EBITDA ratio, consistent with a single-A credit rating.
• North America Personal Care grew value share by 20 basis points and volume share by 90 basis points in 2025.
• Kleenex achieved its highest share in North America in the last 9 years in 2025.
• Ranked #2 overall CPG by customers in the 2025 Advantage Survey, and #1 in key sub-categories like reputation and customer relationship.

Negatives

• Operating in a dynamic and turbulent external environment, including pressure on consumers, retailers, and geopolitical volatility.
• Experienced an uptick in competitive promotion activity in the third and fourth quarters of 2025.
• Global weighted average category growth slowed to approximately 60 basis points in Q4 2025, from a run-rate of approximately 2% during the prior 9 months.
• Exited roughly $650 million of private label business, which had a 330 basis point impact on North America Operating Profit in 2025.
• Navigated headwinds such as changes in the global tariff environment and short-term impacts from private label business exits.
• The International Family Care & Professional (IFP) transaction will result in dilution to Adjusted EPS in the second half of 2026.
• The Kenvue acquisition is expected to result in mid-single digit dilution to Adjusted EPS in 2027 versus the standalone plan, reflecting impacts of debt issuance, deal amortization, synergy timing, and base business reinvestment.

Risks

• Actual results may differ from forward-looking statements due to various risks and uncertainties.
• Risks related to the pending mergers with Kenvue, including that anticipated benefits and synergies may not be realized, financing terms may be less favorable, the merger may not be completed timely or at all, and potential litigation.
• Risks related to the pending International Family Care & Professional (IFP) transaction, including delays or failure to complete, significant transaction and separation costs, adverse market reactions, regulatory or legal challenges, and operational disruptions.
• Risks that the anticipated benefits of the 2024 Transformation Initiative may not be realized.
• Impacts from the war in Ukraine, including responses of consumers, customers, suppliers, and sanctions.
• Government trade or similar regulatory actions, including tariffs, affecting supply chain, commodity costs, and consumer spending.
• Pandemics, epidemics, fluctuations in foreign currency exchange rates, and the prices and availability of raw materials.
• Supply chain disruptions, disruptions in capital and credit markets, and counterparty defaults.
• Failure to realize expected benefits or synergies from acquisition and disposition activity.
• Impairment of goodwill and intangible assets.
• Changes in customer preferences, severe weather conditions, regional instabilities, and hostilities.
• Potential competitive pressures on selling prices for products and energy costs.
• General economic and political conditions globally and in markets where the company operates.
• Ability to maintain key customer relationships.
• Product liability litigation or government/regulatory action, including product efficacy or safety concerns leading to recalls.
• Inflation and other economic factors such as interest rate and currency exchange rate fluctuations.
• Challenges inherent in new product research and development, and uncertainty of commercial success for new and existing products.
• Challenges to intellectual property protections, including counterfeiting.
• Ability to successfully execute business development strategy and other strategic plans.
• Changes to applicable laws and regulations and other requirements imposed by stakeholders.

Future Outlook

Kimberly-Clark expects 2026 to be an 'on-algorithm year,' targeting organic growth in line with or ahead of category growth (approximately 2% last year) for its North America and International Personal Care businesses. Adjusted Operating Profit is projected for mid-to-high single-digit constant-currency growth, with Adjusted EPS from Continuing Operations expected to see double-digit constant-currency growth, partly due to a 30% increase in Income from Equity Companies. Total Adjusted EPS attributable to Kimberly-Clark is anticipated to be flat year-over-year on a constant-currency basis, impacted by the International Family Care & Professional (IFP) transaction. The company plans to accelerate capital investments to $1.3 billion and expects to deliver approximately $2 billion in Adjusted Free Cash Flow. Beyond 2026, the Kenvue acquisition is projected to cause mid-single-digit Adjusted EPS dilution in 2027, followed by significant accretion in 2028, leading to an on-algorithm Adjusted EPS growth (mid-to-high single-digit CAGR) from 2026 to 2028. The company will provide more details on its innovation pipeline and commercial engine at the upcoming CAGNY conference.

Management Comments

• "Powering Care has put Kimberly-Clark on a virtuous cycle of growth and positioned this great American company for a better future. We have the right foundation and a proven playbook to capitalize on our pending acquisition of Kenvue." Mike Hsu, Chairman and CEO.
• "Acquiring Kenvue, a powerful next step in our transformation that will compound our momentum. It will advance our trajectory toward higher growth, higher margin spaces, and create a global health and wellness leader positioned to serve consumers at every stage of life." Mike Hsu, Chairman and CEO.
• "We haven't seen anything that would change our view on the potential of this combination [Kenvue acquisition]. We still see generational value creation opportunity by putting these two companies together." Russ Torres, President and COO.
• "A key part to the equation for us growing is to meet consumer demand at every tier... developing that premium segment... there's very, very significant upside in that." Russ Torres, President and COO.
• "We've had no less of a focus on productivity, internationally... leveraging our global scale... to help drive costs down." Russ Torres, President and COO.

Industry Context

The company operates in a challenging external environment characterized by pressure on consumers, retailers, and geopolitical volatility, alongside an uptick in competitive promotion activity. Despite these headwinds, Kimberly-Clark's categories, being essential and intimate (personal care, health and wellness), are resilient and durable as consumers are less willing to make substitutions. The company notes that local Chinese competition is expanding into new markets from Latin America to North America and Eastern Europe, indicating a shifting competitive landscape. Kimberly-Clark's strategy focuses on innovation-led growth and meeting consumer demand across all price tiers to navigate these challenges.

Comparison to Industry Standards

• Achieved industry-leading gross productivity of 6.2% of adjusted COGS for FY25 and 7.2% for Q425.
• Was one of the first in the industry to successfully pivot to volume-plus-mix led growth following the last inflationary super cycle.
• Was one of the first peers to return Gross Margins to pre-pandemic levels in the second half of 2023.
• Ranked as the #2 overall CPG by customers in the 2025 Advantage Survey, out of approximately 80 top CPG companies, having previously been ranked #1 for three consecutive years.
• Achieved #1 ranking in key sub-categories, including reputation and relationship with one of its most important customers.
• Huggies Little Movers HuggFit 360 was named Disposable Diaper Product of the Year by the Baby Innovation Awards, a leading independent body in the Baby Care industry.
• Huggies with Snug & Dry Softness was named the best overall disposable diaper of the year by Good Housekeeping.

Legal Proceedings

• Risks include "litigation related to the mergers" (Kenvue acquisition).

Stakeholder Impact

• Shareholders: Expected to benefit from significant value creation, solid EPS accretion from the Kenvue acquisition by year two, growing dividends, and consistent double-digit total shareholder returns.
• Consumers: Will benefit from consumer-directed, pioneering innovation, breakthrough marketing, differentiated products, enhanced brand love, and efforts to crush stigma in intimate categories, ultimately raising the standard of care.
• Customers (Retailers): Strategic partnerships are being strengthened, with the company being recognized for delivering outstanding value and partnership, and achieving high rankings in customer surveys.
• Employees: The Integration Management Office for the Kenvue acquisition is staffed with leaders from both companies and external specialists, indicating a collaborative and disciplined approach to integration.

Next Steps

• Hold a separate live question-and-answer session with analysts.
• Present at the CAGNY conference next month (February 2026) to detail the innovation pipeline and commercial engine, and execution plans for the Kenvue acquisition.
• Kenvue shareholders to vote on the merger on January 29, 2026.
• Complete filing all applicable international antitrust jurisdictions for the Kenvue acquisition by early February 2026.
• Complete the International Family Care & Professional joint venture transaction with Suzano by mid-2026.
• Close the Kenvue acquisition in the second half of 2026.
• Provide more detail as Kenvue integration milestones are achieved.
• Continue to scale and deploy the digital social media model more broadly in International Personal Care markets.
• Accelerate capital investments to approximately $1.3 billion in 2026 to support growth and transformation plans.

Key Dates

Recommendation

Kimberly-Clark has demonstrated strong operational execution and financial performance in 2025, exceeding productivity targets and successfully pivoting to volume-plus-mix led growth sooner than anticipated. The strategic transformation, including portfolio optimization and the pending Kenvue acquisition, positions the company for higher-growth, higher-margin categories and significant synergy realization ($2.1 billion). While near-term dilution from the Kenvue deal is expected in 2027, substantial accretion is projected for 2028, aligning with a robust long-term growth algorithm. The company's strong cash flow generation, disciplined capital deployment, and commitment to a healthy balance sheet further underpin its investment appeal. The positive outlook for 2026, aiming for the high end of operating profit growth, suggests continued momentum and value creation for shareholders.

Keywords

Kimberly-Clark, Kenvue, Q4 2025 Earnings, Powering Care Strategy, Consumer Health, Personal Care, Acquisition, Synergies, Financial Results, Outlook, SEC Filing, Corporate Transformation, Productivity, Innovation, Market Share, Free Cash Flow, International Family Care & Professional, Joint Venture, CPG